EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The prognostic significance of the IASLC grading system in ALK ‐positive invasive non‐mucinous adenocarcinoma of the lung: correlation with clinicopathological features

Dongmei Gu, Jie Bao, Hong Chen, Siyi Chen, Chenxi Shi, Xia Guo, Xiaoyu Zhou, Zhe Lei, Lingchuan Guo, Qianqian Yang

The Journal of Pathology: Clinical Research · 2026-05 · 12 (3)

DOI: 10.1002/2056-4538.70093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, online erschienen am 12.05.2026. Verfasst von Dongmei Gu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Lung Neoplasms, Adenocarcinoma of Lung, Biomarkers, Tumor. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Program of Jiangsu Provincial HealthCommission, Suzhou Basic Research Program, Suzhou Science and Technology Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognostic value of the International Association for the Study of Lung Cancer (IASLC) grading system in anaplastic lymphoma kinase (ALK)‐positive invasive non‐mucinous adenocarcinoma (INMA) remains unclear, particularly in relation to the tumor immune microenvironment (TIME). This retrospective study included 108 patients with ALK‐positive INMA. Tumors were graded according to the IASLC system. Clinicopathological features, progression‐free survival (PFS), and overall survival (OS) were analyzed. Immunohistochemistry was used to assess PD‐L1 expression and tumor‐infiltrating lymphocytes (TILs), including CD4+, CD8+, and FoxP3+ regulatory T cells. Associations were evaluated using Kaplan–Meier analysis, Cox regression models, and correlation analyses. Higher IASLC grades were significantly associated with more aggressive pathological features, elevated PD‐L1 expression, and shorter progression‐free survival (PFS). Higher‐grade tumors exhibited enhanced T‐cell infiltration, predominantly driven by CD8+ T cells, while no significant difference in FoxP3+ Treg density was observed across grades. Notably, the CD4:CD8 ratio decreased, whereas the CD8:FoxP3 ratio increased with tumor grade, indicating a shift toward a CD8‐dominant immune microenvironment. Importantly, this cytotoxic predominance occurred in parallel with elevated PD‐L1 expression, suggesting an immune context consistent with adaptive immune resistance rather than effective anti‐tumor immunity. The IASLC grading system effectively identifies a high‐risk subgroup of ALK‐positive INMA characterized by aggressive tumor behavior and a dynamically regulated immune microenvironment. High‐grade tumors exhibit features of immune engagement coupled with checkpoint‐mediated regulation, supporting a model of adaptive immune resistance. These findings underscore the necessity of combination therapeutic strategies that simultaneously target ALK and immune checkpoint modulation in high‐grade INMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseLung NeoplasmsAdenocarcinoma of LungBiomarkers, TumorHumansFemaleMaleRetrospective StudiesMiddle AgedLymphocytes, Tumor-InfiltratingNeoplasm GradingTumor MicroenvironmentPrognosisAgedAdultB7-H1 AntigenProgression-Free Survival

Stichwörter der Autor:innen

International Association for the Study of Lung Cancer (IASLC)PD‐L1 expressionT lymphocytelung invasive non‐mucinous adenocarcinoma (INMA)prognostic stratificationthe anaplastic lymphoma kinase (ALK)

Substanzen

Anaplastic Lymphoma KinaseALK protein, humanBiomarkers, TumorB7-H1 AntigenCD274 protein, human

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • School of Public Health, Shandong Second Medical University, Weifang, China.
  • Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China.

Förderung

  • Research Program of Jiangsu Provincial HealthCommission
  • Suzhou Basic Research Program
  • Suzhou Science and Technology Development Program
  • Suzhou University's External Research Project

Zitieren

APA

Gu, D., Bao, J., Chen, H., Chen, S., Shi, C., Guo, X., Zhou, X., Lei, Z., Guo, L., & Yang, Q. (2026). The prognostic significance of the IASLC grading system in ALK ‐positive invasive non‐mucinous adenocarcinoma of the lung: correlation with clinicopathological features. The Journal of Pathology: Clinical Research, 12(3). https://doi.org/10.1002/2056-4538.70093

Vancouver

Gu D, Bao J, Chen H, Chen S, Shi C, Guo X, et al. The prognostic significance of the IASLC grading system in ALK ‐positive invasive non‐mucinous adenocarcinoma of the lung: correlation with clinicopathological features. The Journal of Pathology: Clinical Research. 2026;12(3). doi:10.1002/2056-4538.70093

BibTeX
@article{Gu2026,
  author = {Gu, Dongmei and Bao, Jie and Chen, Hong and Chen, Siyi and Shi, Chenxi and Guo, Xia and Zhou, Xiaoyu and Lei, Zhe and Guo, Lingchuan and Yang, Qianqian},
  title = {The prognostic significance of the IASLC grading system in ALK ‐positive invasive non‐mucinous adenocarcinoma of the lung: correlation with clinicopathological features},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2026},
  volume = {12},
  number = {3},
  doi = {10.1002/2056-4538.70093}
}
Kostenlos starten →